kresmion.
Pull a receipt

Inhibitor Therapeutics, Inc. (INTI)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.08
As of

Kresmion compiles this page from INTI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Inhibitor Therapeutics, Inc. (INTI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-18.

As of . Source: SEC EDGAR filings for INTI. Method and limitations.

COMPANY DOSSIER

See the full INTI dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for INTI on one page. Preview it with sample data, then open it live with a free account.

Preview the INTI dossier

Active events for INTI

No recent events on INTI in the last 180 days.

FREE, NO ACCOUNT

Every event on INTI, as it fires

New filings, 13F moves and cross asset events on INTI land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, INTI

Going concern statement

INTI's 10-Q filed Aug 14, 2026 states:

These conditions and events raise substantial doubt about our ability to continue as a going concern.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on INTI

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in INTI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on INTI in the last 180 days.

Upstream: SEC EDGAR filings for INTI

Kresmion, "Inhibitor Therapeutics, Inc. (INTI) institutional holdings and SEC filings", data as of 2026-09-18, https://kresmion.com/research/INTI. Upstream data: SEC EDGAR filings for INTI.

Link to this data (HTML):

<a href="https://kresmion.com/research/INTI">Inhibitor Therapeutics, Inc. (INTI) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow INTI on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to INTI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the INTI dossier
Share

The INTI intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.